F508del-CFTR correctors (Traffick Therapeutics/Nuchem Therapeutics/Amorchem)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameF508del-CFTR correctors (Traffick Therapeutics/Nuchem Therapeutics/Amorchem)
Drug Alias NameCFTR protein modulators (Traffick)F508del-CFTR correctors (Vertex Pharmaceuticals)NU-001CFTR protein modulators (Vertex Pharmaceuticals)NU-002 +[7] 
ClassificationSmall molecules
Mechanisms of ActionCystic fibrosis transmembrane conductance regulator modulators
TargetsCystic fibrosis transmembrane conductance regulator
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTraffick Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVertex Pharmaceuticals GmbhTraffick Therapeutics IncNuChem Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A